Enliven Therapeutics Inc. (ELVN)

NASDAQ: ELVN · Real-Time Price · USD

18.65

-0.26 (-1.37%)

At close: Apr 29, 2025, 3:59 PM

17.91

-3.97%

Pre-market: Apr 30, 2025, 04:07 AM EDT

Enliven Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-89.02M	-71.58M	-37.66M	-24.74M	-18.97M	-23.46M	-11.34M	n/a
Depreciation & Amortization	317K	297K	215K	115K	45K	33K	n/a	n/a
Stock-Based Compensation	20.17M	12.91M	3.19M	1.92M	130K	899K	555K	n/a
Other Working Capital	-5.35M	3.65M	27K	1.83M	292K	-77K	758K	478K
Other Non-Cash Items	-118K	-4.3M	1.74M	3.81M	9.68M	196K	848K	-7.93M
Deferred Income Tax	n/a	n/a	n/a	-3.81M	n/a	-215K	n/a	n/a
Change in Working Capital	-4.54M	1.4M	438K	3.57M	583K	673K	1.24M	-188K
Operating Cash Flow	-73.19M	-61.27M	-32.08M	-19.13M	-8.53M	-21.88M	-8.78M	-8.79M
Capital Expenditures	-44K	-149K	-612K	-191K	-461K	-140K	n/a	n/a
Cash Acquisitions	n/a	n/a	35M	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-350.74M	-268.26M	-35M	-47.56M	-64.2M	-23.92M	n/a	n/a
Sales Maturities Of Investments	313.91M	120M	41.88M	45.94M	47.5M	n/a	n/a	n/a
Other Investing Acitivies	873K	n/a	-41.88M	1.62M	16.7M	n/a	n/a	n/a
Investing Cash Flow	-36M	-148.41M	-612K	-191K	-461K	-24.06M	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	-2M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	93.98M	234.29M	-1.8M	-1.02M	130.51M	n/a	6.49M	11M
Financial Cash Flow	133.16M	234.29M	-1.8M	-1.02M	130.51M	43.58M	6.49M	11M
Net Cash Flow	23.98M	24.61M	-34.49M	-20.34M	121.52M	-2.45M	-2.29M	2.21M
Free Cash Flow	-73.24M	-61.42M	-32.69M	-19.32M	-8.99M	-22.02M	-8.78M	-8.79M